Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Straumann Holding    STMN   CH0012280076

STRAUMANN HOLDING

(STMN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
03/13/2019 03/14/2019 03/15/2019 03/18/2019 03/19/2019 Date
804.5(c) 810.5(c) 823.5(c) 811.5(c) 806(c) Last
37 551 27 042 48 725 35 106 39 207 Volume
+1.26% +0.75% +1.60% -1.46% -0.68% Change
More quotes
Financials (CHF)
Sales 2019 1 567 M
EBIT 2019 413 M
Net income 2019 348 M
Finance 2019 279 M
Yield 2019 0,78%
Sales 2020 1 781 M
EBIT 2020 482 M
Net income 2020 419 M
Finance 2020 464 M
Yield 2020 0,91%
P/E ratio 2019 37,01
P/E ratio 2020 31,40
EV / Sales2019 7,99x
EV / Sales2020 6,93x
Capitalization 12 798 M
More Financials
Company
Straumann Holding specializes in the design, manufacture and marketing of dental products and materials. Net sales break down by activity as follows: - sales of dental products (60.8%): implants, surgical instruments, diagnostic tools (distance indicators for implants, drilling guides, etc.),... 
More about the company
Surperformance© ratings of Straumann Holding
Trading Rating : Investor Rating :
More Ratings
Latest news on STRAUMANN HOLDING
03/13Straumann Group presents a series of change-making innovations at the 38th In..
TE
03/12Anthogyr joins the Straumann Group
TE
02/19EUROPE : European shares slip from October highs as banks weigh
RE
02/19GLOBAL MARKETS LIVE : Walmart, Honda, Tom Tailor, Facebook…
02/19Straumann posts strong Q4, lifting full-year organic revenue growth to 19% as..
TE
01/22AD-HOC RELEASE : Alastair Robertson to join Straumann Group as Head of Global Pe..
TE
01/17AD-HOC : Straumann Group set to enter clear aligner market in China
TE
01/15Straumann Group announces leadership succession plan
TE
2018Straumann Group and Nobel Biocare settle patent dispute
TE
2018Straumann partners with Z-Systems to offer the broadest range of ceramic impl..
TE
More news
Analyst Recommendations on STRAUMANN HOLDING
More recommendations
Stock Trading Strategies
STRAUMANN HOLDING - 02/27
There is still some upside potential
BUY
More Stock Trading Analysis
Sector news : Medical Prosthetics
03/18ESSILORLUXOTTICA : hires headhunter to search for CEO - sources
RE
03/14ABBOTT LABORATORIES : Vascular Gets FDA Approval for New Indication for Valve Re..
DJ
03/14GLOBAL MARKETS LIVE : Boeing, Facebook, Volkswagen, Tesla…
03/14STRYKER : Buys OrthoSpace Ltd. for Initial $110 Million
DJ
03/13LEONARDO DEL VECCHIO : Del Vecchio wants to split powers with aide as EssilorLux..
RE
More sector news : Medical Prosthetics
Chart STRAUMANN HOLDING
Duration : Period :
Straumann Holding Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 826  CHF
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
Marco Gadola Chief Executive Officer
Gilbert Achermann Chairman
Gerhard Bauer Head-Research, Development & Operations
Peter Hackel Chief Financial Officer
Thomas Straumann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
STRAUMANN HOLDING31.31%12 878
ABBOTT LABORATORIES8.99%138 463
MEDTRONIC PLC1.02%123 238
STRYKER CORPORATION23.50%72 140
BECTON, DICKINSON AND COMPANY8.59%65 832
ESSILORLUXOTTICA-4.75%52 063